help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2005-0476
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
146/11/4943    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Köster, A.
Right arrow Articles by Eacho, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Köster, A.
Right arrow Articles by Eacho, P.
Endocrinology Vol. 146, No. 11 4943-4950
Copyright © 2005 by The Endocrine Society

Transgenic Angiopoietin-Like (Angptl)4 Overexpression and Targeted Disruption of Angptl4 and Angptl3: Regulation of Triglyceride Metabolism

Anja Köster, Y. Bernice Chao, Marian Mosior, Amy Ford, Patricia A. Gonzalez-DeWhitt, John E. Hale, Deshan Li, Yubin Qiu, Christopher C. Fraser, Derek D. Yang, Josef G. Heuer, S. Richard Jaskunas and Patrick Eacho

Lilly Research Laboratories (A.K., Y.B.C., M.M., A.F., P.A.G.-D., J.E.H., D.L., D.D.Y., J.G.H., S.R.J., P.E.), Eli Lilly & Company, Indianapolis, Indiana 46285; and Millennium Pharmaceutical Inc. (Y.Q., C.C.F.), Cambridge, Massachusetts 02139

Address all correspondence and requests for reprints to: Anja Köster, Lilly Research Laboratories, Eli Lilly & Company, Indianapolis, Indiana 46225. E-mail: koester_anja{at}lilly.com.

Lipoprotein lipase (LPL) is a key regulator of triglyceride clearance. Its coordinated regulation during feeding and fasting is critical for maintaining lipid homeostasis and energy supply. Angiopoietin-like (Angptl)3 and Angptl4 are secreted proteins that have been demonstrated to regulate triglyceride metabolism by inhibiting LPL. We have taken a targeted genetic approach to generate Angptl4- and Angptl3-deficient mice as well as transgenic mice overexpressing human Angptl4 in the liver. The Angptl4 transgenic mice displayed elevated plasma triglycerides and reduced postheparin plasma (PHP) LPL activity. A purified recombinant Angptl4 protein inhibited mouse LPL and recombinant human LPL activity in vitro. In contrast to the transgenic mice, Angptl4-deficient mice displayed hypotriglyceridemia and increased PHP LPL activity, with greater effects in the fasted compared with the fed state. Angptl3-deficient mice also displayed hypotriglyceridemia with elevated PHP LPL activity, but these mice showed a greater effect in the fed state. Mice deficient in both Angptl proteins showed an additive effect on plasma triglycerides and did not survive past 2 months of age. Our results show that Angptl3 and Angptl4 function to regulate circulating triglyceride levels during different nutritional states and therefore play a role in lipid metabolism during feeding/fasting through differential inhibition of LPL.




This article has been cited by other articles:


Home page
J. Lipid Res.Home page
G. M. Dallinga-Thie, A. J. Zonneveld-de Boer, L. C. van Vark-van der Zee, R. van Haperen, T. van Gent, H. Jansen, R. De Crom, and A. van Tol
Appraisal of hepatic lipase and lipoprotein lipase activities in mice
J. Lipid Res., December 1, 2007; 48(12): 2788 - 2791.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
A. S. Andrew, V. Bernardo, L. A. Warnke, J. C. Davey, T. Hampton, R. A. Mason, J. E. Thorpe, M. A. Ihnat, and J. W. Hamilton
Exposure to Arsenic at Levels Found in U.S. Drinking Water Modifies Expression in the Mouse Lung
Toxicol. Sci., November 1, 2007; 100(1): 75 - 87.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. Lichtenstein, J. F.P. Berbee, S. J. van Dijk, K. W. van Dijk, A. Bensadoun, I. P. Kema, P. J. Voshol, M. Muller, P. C.N. Rensen, and S. Kersten
Angptl4 Upregulates Cholesterol Synthesis in Liver via Inhibition of LPL- and HL-Dependent Hepatic Cholesterol Uptake
Arterioscler. Thromb. Vasc. Biol., November 1, 2007; 27(11): 2420 - 2427.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
C. J. A. Moen, A. P. Tholens, P. J. Voshol, W. de Haan, L. M. Havekes, P. Gargalovic, A. J. Lusis, K. W. van Dyk, R. R. Frants, M. H. Hofker, et al.
The Hyplip2 locus causes hypertriglyceridemia by decreased clearance of triglycerides
J. Lipid Res., October 1, 2007; 48(10): 2182 - 2192.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
G. Wu, L. Zhang, J. Gupta, G. Olivecrona, and T. Olivecrona
A transcription-dependent mechanism, akin to that in adipose tissue, modulates lipoprotein lipase activity in rat heart
Am J Physiol Endocrinol Metab, October 1, 2007; 293(4): E908 - E915.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
U. Desai, E-C. Lee, K. Chung, C. Gao, J. Gay, B. Key, G. Hansen, D. Machajewski, K. A. Platt, A. T. Sands, et al.
Lipid-lowering effects of anti-angiopoietin-like 4 antibody recapitulate the lipid phenotype found in angiopoietin-like 4 knockout mice
PNAS, July 10, 2007; 104(28): 11766 - 11771.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Galaup, A. Cazes, S. Le Jan, J. Philippe, E. Connault, E. Le Coz, H. Mekid, L. M. Mir, P. Opolon, P. Corvol, et al.
Angiopoietin-like 4 prevents metastasis through inhibition of vascular permeability and tumor cell motility and invasiveness
PNAS, December 5, 2006; 103(49): 18721 - 18726.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
V. Sukonina, A. Lookene, T. Olivecrona, and G. Olivecrona
Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue
PNAS, November 14, 2006; 103(46): 17450 - 17455.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
F. G. Schaap, M. C. Nierman, J. F. P. Berbee, H. Hattori, P. J. Talmud, S. F. C. Vaessen, P. C. N. Rensen, R. A. F. M. Chamuleau, J. A. Kuivenhoven, and A. K. Groen
Evidence for a complex relationship between apoA-V and apoC-III in patients with severe hypertriglyceridemia
J. Lipid Res., October 1, 2006; 47(10): 2333 - 2339.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Fugier, J.-J. Tousaint, X. Prieur, M. Plateroti, J. Samarut, and P. Delerive
The Lipoprotein Lipase Inhibitor ANGPTL3 Is Negatively Regulated by Thyroid Hormone
J. Biol. Chem., April 28, 2006; 281(17): 11553 - 11559.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Mandard, F. Zandbergen, E. van Straten, W. Wahli, F. Kuipers, M. Muller, and S. Kersten
The Fasting-induced Adipose Factor/Angiopoietin-like Protein 4 Is Physically Associated with Lipoproteins and Governs Plasma Lipid Levels and Adiposity
J. Biol. Chem., January 13, 2006; 281(2): 934 - 944.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society